Medical

10 Essential Questions for Reevaluating Your Medical Device Assembly Process

Medical device manufacturers that assemble devices and equipment must meet stringent FDA regulations for quality and product consistency, which makes rigorous process control essential. Fluids for medical device manufacturing can be extremely expensive. It is vital to have quality assembly equipment that generates consistent and accurate results, without fluid contamination, to avoid costly waste.

Posted in: Bio-Medical, Medical, White Papers, MDB

Read More >>

A Computing Platform Based on 4th Generation Intel® Core™ Processors That Provides Flexible and Expandable I/Os for In Vitro Diagnostics Instruments

In the medical world, In Vitro Diagnostic (IVD) instruments are ubiquitously used in hospital labs, doctor offices, and at home. IVD instruments are designed for various qualitative or quantitative diagnostic procedures, commonly called assays, in assessing or measuring the target entity out of the samples. For different assays, IVD instruments are designed with the goal to automate the process, combining and streamlining labor-intensive steps. Based on their applications, these steps could be combined in one self-contained platform, in several discrete platforms, or a combination of both, depending on the application’s needs. Furthermore, some platforms use modularization, starting with minimum modules and then adding modules as the needs grow. This enables laboratories to pick and choose optional modules as needed. With modular design in mind, most IVD instrument providers start with a small footprint platform, and enhance the design with an expandability mechanism to accommodate more modules for future product enhancements. In order to be most effective, an embedded computing platform used in an IVD instrument needs to be easy-to-configure and easy-to-expand.

Posted in: Bio-Medical, Medical, White Papers, MDB

Read More >>

Broadening the Scope of User Requirements When Selecting Valves for Medical Devices

It is paramount to move beyond the specifications when identifying the best valve for a device. By broadening the scope of user requirements, one can ensure that a valve will function as expected over the device’s entire life cycle - from manufacturing through clinical use. Below are several requirements worthy of consideration. Although they are important, they often are unshared unless the valve supplier and device engineer engage in open communication early in the purchasing cycle.

Posted in: Bio-Medical, Custom & Contract Manufacturing, Medical, White Papers, MDB

Read More >>

Primer on Laser Micromachining of Polymer-Based Life Science Products

Resonetics is the leader in laser micromachining polymers for life sciences. We solve challenges to manufacture sub-millimeter features. We laser material up to 1mm thick with features down to 2µm in diameter. The Lightspeed ADL™ is equipped with laser workstations for process development and prototyping. Resonetics offers the largest capacity for laser micromachining polymers in ultra-violet wavelengths. Our 64,000 sq. ft. site has a 6,000 sq. ft. Class 8 cleanroom and more than 50 laser workstations.

Posted in: Medical, White Papers, MDB

Read More >>

Navigating the Intellectual Property Roadblocks to Open Innovation

In an effort to incorporate outside sources of innovation into their new product acquisition programs, there has been a significant increase in the number of firms opening their organizational boundaries to external ideas. Over the past few years, large multinational companies such as Kraft, IBM and 3M have initiated active open innovation (OI) programs. The benefits to the organization of accepting new product ideas are lower research and development costs and the more rapid procurement of new products to fuel sales, and to the submitter, this can be financially rewarding if their idea is selected for product development or commercialization. Consumer products giant Procter & Gamble estimates that as many as 1.5 million researchers and scientists could contribute materially to the efforts of their own 7,500 researchers and scientists in corporate research and development. However, the economic benefits of open innovation can be diminished if organizations do not effectively manage the legal issues and logistical challenges that are presented. They include the quality/quantity of submissions, and once received, what is the most efficient way to process the submissions received?

Posted in: Medical, White Papers

Read More >>